SALE
市場調査レポート

中国の整形外科用バイオマテリアル市場

Chinese Orthopedic Biomaterials Market

発行 iData Research Inc. 商品コード 274587
出版日 ページ情報 英文 110 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=106.02円で換算しております。
10% OFF 2016年07月31日まで 期間限定キャンペーン

ご注意: Single Userライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。
認証されたPC上のみでの閲覧となっております。

Back to Top
中国の整形外科用バイオマテリアル市場 Chinese Orthopedic Biomaterials Market
出版日: 2013年06月26日 ページ情報: 英文 110 Pages
概要

中国における整形外科用バイオマテリアル市場は、2019年までに5億2,230万米ドルに近づくと予測されています。骨移植片代替物セグメントは、中国の整形外科用バイオマテリアル市場の大部分を構成する見込みです。

当レポートでは、中国の整形外科用バイオマテリアル(生体材料)市場について調査分析し、10ヵ年予測を提供しており、競合企業の分析、戦略的機会の特定、セグメント別の市場概要・動向分析、市場の促進要因と阻害要因、競合情勢、および顧客のフィードバックと市場モニタリングなどをまとめ、概略以下の構成でお届けいたします。

第1章 エグゼクティブサマリー

第2章 調査手法

第3章 中国の整形外科用バイオマテリアル市場の概要

  • イントロダクション
  • 為替レート
  • 処置数
  • 市場概要
  • 動向分析
  • 市場促進要因と阻害要因
  • 競合分析
  • M&A

第4章 骨移植片代替物市場

  • イントロダクション
  • 市場概要
  • 市場分析と予測
  • 市場促進要因と阻害要因
  • 競合分析

第5章 ヒアルロン酸関節内補充治療市場

  • イントロダクション
  • 市場概要
  • 市場分析と予測
  • 市場促進要因と阻害要因
  • 競合分析

付録:(オプション)

略語

目次
Product Code: iDATA_CHOB13_RPT

The Chinese orthopedic biomaterials market is expected to approach $522.3 million by 2019. The bone graft substitute segment is expected to constitute the majority of the Chinese orthopedic biomaterials market.

The Chinese orthopedic biomaterials market comprises bone graft substitutes which is segmented into allografts, demineralized bone matrices (DBM) and synthetics, and hyaluronic acid (HA) viscosupplementation. The market has seen increased interest in domestic competitors and some domestic competitors are in the process of clinical trials for synthetic, DBM, and bone morphogenetic protein (BMP) products. Further growth in the overall market will be fuelled by the Chinese government improving healthcare coverage across the country, leading to an increase in the number of Chinese people with more disposable income. The previous drivers are magnified by the increasing population of elderly, and the increased acceptance of surgery as a solution.

Scope:

This report pertains to a forecast period of 10 years (2009 - 2019) for China.

Report Contents:

  • Competitor Analysis
  • Identified Strategic Opportunities
  • Market Overview by Segment & Country
  • Trend Analysis by Segment & Country
  • Market Drivers & Limiters
  • Mergers & Acquisitions
  • Customer Feedback and Market Monitoring

Main Markets Included:

  • Bone Graft Substitute
  • Hyaluronic Acid Viscosupplementation

Sub-Segments Included:

  • Synthetic Allograft
  • Demineralized Bone Matrix
  • Cervical Spine
  • Thoracolumbar Spine
  • Trauma & Reconstruction
  • Craniomaxillofacial
  • Single-injection products
  • Three-injection cycle products
  • Five-injection cycle products

Companies Included:

  • Wright Medical
  • Bloomage Freda Biopharm
  • Shanghai Haohai Biological
  • Kunming Baker Norton
  • Shanghai Baijiayi
  • Xin Kang Cheng
  • Shanxi Aurui
  • Biolu
  • Hubei Lianjie
  • Shanghai Anjiu
  • Biocomposites
  • DePuy Synthes NovaBone
  • Rebone

Others Include:

Award Trade Corporation (Kunming), Beijing Fito Medical, Beijing St. Jane Medical, Liweize Medical Devices, Shanghai Medcare, Shenzhen SMARL, and various domestic companies

Reasons To Buy:

This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “ground up” approach, which includes primary and secondary research methods.

Table of Contents

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

  • 1.1. CHINESE MARKET FOR ORTHOPEDIC BIOMATERIALS
  • 1.2. GROWTH TRENDS BY SEGMENT
  • 1.3. PROCEDURES
  • 1.4. BONE GRAFT SUBSTITUTE MARKET
  • 1.5. HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
  • 1.6. COMPETITIVE ANALYSIS

RESEARCH METHODOLOGY

  • 2.1. RESEARCH SCOPE
  • 2.2. IDATA'S 9-STEP METHODOLOGY
    • Step 1: Project Initiation & Team Selection
    • Step 2: Prepare Data Systems and Perform Secondary Research
    • Step 3: Preparation for Interviews & Questionnaire Design
    • Step 4: Performing Primary Research
    • Step 5: Research Analysis: Establishing Baseline Estimates
    • Step 6: Market Forecast and Analysis
    • Step 7: Identify Strategic Opportunities
    • Step 8: Final Review and Market Release
    • Step 9: Customer Feedback and Market Monitoring

CHINESE ORTHOPEDIC BIOMATERIALS MARKET

  • 3.1. INTRODUCTION
    • 3.1.1. Growth Factors
    • 3.1.2. Bone Graft Substitutes
    • 3.1.3. Hyaluronic Acid Viscosupplementation
  • 3.2. CURRENCY EXCHANGE RATE
  • 3.3. PROCEDURES
    • 3.3.1. Total Orthopedic Bone Graft Substitute Procedures by Indication
    • 3.3.2. Total Orthopedic Bone Graft Substitute Procedures by Segment
    • 3.3.3. Bone Graft Substitute Procedures
    • 3.3.4. Hyaluronic Acid Viscosupplementation Procedures
  • 3.4. MARKET OVERVIEW
  • 3.5. TREND ANALYSIS
  • 3.6. MARKET DRIVERS AND LIMITERS
    • 3.6.1. Market Drivers
    • 3.6.2. Market Limiters
  • 3.7. COMPETITIVE ANALYSIS
    • 3.7.1. Leading Competitors
    • 3.7.2. Market Concentration
  • 3.8. MERGERS AND ACQUISITIONS

BONE GRAFT SUBSTITUTE MARKET

  • 4.1. INTRODUCTION
    • 4.1.1.1. Autograft
    • 4.1.1.2. Non-Proprietary Allograft
    • 4.1.1.3. Demineralized Bone Matrix
    • 4.1.1.4. Synthetic
    • 4.1.2. Volumes Represented per Procedure
  • 4.2. MARKET OVERVIEW
  • 4.3. MARKET ANALYSIS & FORECAST
    • 4.3.1. Allograft Market
      • 4.3.1.1. Total Allograft Market
    • 4.3.2. Synthetic Market
      • 4.3.2.1. Total Synthetic Market
    • 4.3.3. Demineralized Bone Matrix Market
      • 4.3.3.1. Total DBM Market
    • 4.3.4. Market by Indication
    • 4.3.5. Cervical Market
    • 4.3.6. Thoracolumbar Market
    • 4.3.7. Trauma & Reconstruction Market
    • 4.3.8. Craniomaxillofacial Market
      • 4.3.8.1. Craniomaxillofacial Market
  • 4.4. DRIVERS AND LIMITERS
    • 4.4.1. Market Drivers
    • 4.4.2. Market Limiters
  • 4.5. COMPETITIVE ANALYSIS

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

  • 5.1. INTRODUCTION
    • 5.1.1.1. Single-Injection Products
    • 5.1.1.2. Three-Injection Cycle Products
    • 5.1.1.3. Five-Injection Cycle Products
  • 5.2. MARKET OVERVIEW
  • 5.3. MARKET ANALYSIS & FORECAST
    • 5.3.1. Single Injection Market
    • 5.3.2. Three Injection Cycle Market
    • 5.3.3. Five Injection Cycle Market
  • 5.4. DRIVERS AND LIMITERS
    • 5.4.1. Market Drivers
    • 5.4.2. Market Limiters
  • 5.5. COMPETITIVE ANALYSIS

APPENDIX: (OPTIONAL)

ABBREVIATIONS

Back to Top